微小RNA(miRNA)是一类天然存在的小型(约22个核苷酸长)非编码RNA,可调节转录后基因表达以控制细胞过程、发育、细胞分化和体内平衡。微小RNA对于胚胎、细胞和组织发育至关重要,可调节细胞分化、增殖和凋亡,因此在人类生殖中具有重要意义。同时,miRNA的异常表达或功能被发现与包括癌症在内的各种人类疾病的发生或发展密切相关。鉴于其在生理学和病理学中的重要作用,miRNA正在成为化学生物学研究(包括调节和检测)的新型生物分子靶点。
miRNA的生成涉及多个步骤。大多数 miRNA 都是通过经典生物合成途径产生的,该途径包括 RNA 聚合酶 II 转录以产生初级转录本 (pri-miRNA),以及微处理器复合物裂解以在细胞核中产生发夹结构前体 miRNA (pre-miRNA)。然后,pre-miRNA 被输出到细胞质中,在那里被 Dicer 酶裂解形成双链 RNA 双链。只有双链 RNA 双链中的一条单链形成成熟的 miRNA,并被整合到 RNA 诱导沉默复合物 (RISC) 中,该复合物引导 RISC 中的 Argonaute (AGO) 蛋白与 3' 非翻译区 (UTR) 结合,以抑制蛋白质翻译或促进 mRNA 降解。除了经典 miRNA 生物合成途径外,还存在非经典微处理器独立或 Dicer 独立的 miRNA 生物合成途径。尽管 miRNA 主要参与基因表达的下调,但也有 miRNA 促进基因表达的报道。此外,在特定细胞类型中,miRNA 与其靶标之间的关系并不总是一对一的。事实上,单个 miRNA 可能调节许多 mRNA 靶标,反之,单个 mRNA 靶标也可以受许多 miRNA 调节。
MicroRNAs (miRNAs) are a naturally occurring class of small (approximately 22 nucleotides long) non-coding RNAs that regulate post-transcriptional gene expression to control cellular processes, development, cell differentiation, and homeostasis. MicroRNAs are essential for embryo, cell, and tissue development, regulating cell differentiation, proliferation, and apoptosis, hence their importance in human reproduction. Meanwhile, abnormal expression or function of miRNAs are found to be closely associated with the occurrence or development of various human diseases, including cancers. In light of their significant roles in physiology and pathology, miRNAs are emerging as novel biomolecular targets for chemical-biological studies, including regulation and detection.
Multiple steps are involved in the generation of miRNAs. Most miRNAs are produced by the canonical biogenesis pathway, which involves transcription by RNA polymerase II to make a primary transcript (pri-miRNA) and cleavage by the microprocessor complex to yield a hairpin precursor miRNA (pre-miRNA) in the nucleus. The pre-miRNA is then exported into the cytoplasm, where cleavage by the enzyme Dicer creates a double-stranded RNA duplex. Only a single strand from the double-stranded RNA duplex forms the mature miRNA and is incorporated into the RNA-induced silencing complex (RISC), which guides the binding of Argonaute (AGO) proteins in the RISC to the 3’untranslated region (UTR) to either repress protein translation or promote mRNA degradation. In addition to canonical miRNA biogenesis pathways, non-canonical microprocessor-independent or Dicer-independent miRNA biogenesis pathways also exist. Despite miRNAs being mostly involved in the down-regulation of gene expression, there are reports of miRNAs promoting gene expression. In addition, relationships between miRNAs and their targets are not always one-to-one in a specific cell type. In fact, a single miRNA may regulate many mRNA targets, and conversely, a single mRNA target also can be regulated by many miRNAs.
Cobomarsen (MRG-106) 是一种靶向 miR-155 的寡核苷酸抑制剂,可抑制与细胞存活相关的多条基因通路(JAK/STAT、MAPK/ERK 和 PI3K/AKT),并可用于 B 细胞淋巴瘤的研究。
Farabursen sodium(RGLS8429 sodium;RG1015 sodium)是一种 miR-17 抑制剂,可抑制 miR-17 家族的功能,解除对包括 PKD1 和 PKD2 在内的 miR-17 靶基因的抑制作用并增加 PC1/2 的水平,从而减缓肾囊肿生长、降低肾重与体重的比值并降低囊肿指数和增殖指数,可用于常染色体显性多囊肾病的相关研究。
Farabursen sodium scrambled negative control 是 Farabursen sodium 的乱序阴性对照。
hsa-miR-222-3p inhibitor 是一种全链经过甲氧基修饰的成熟 miRNA 互补单链,它通过特异性结合成熟 miRNA 来阻止 miRNA 与其靶基因的互补配对,从而抑制 miRNA 的功能,可用于 miRNA 功能缺失性(loss-of-function)研究。
LIN28 inhibitor LI71 是一种 LIN28 抑制剂,可有效抑制 LIN28:let-7 结合(IC50: 7 μM),消除 LIN28 介导的 let-7 前体寡尿苷化(IC50: 27 μM),在 LIN28 驱动的癌症研究中具有潜在应用价值,同时通过抑制恶性疟原虫冷休克蛋白 (PfCoSP) 与 DNA 及 α/β 微管蛋白的相互作用而对恶性疟原虫具有抑制作用。
LIN28 inhibitor LI71 enantiomer 是 LIN28 inhibitor LI71 (MS-S04785) 的低活性对映异构体,而 LIN28 inhibitor LI71 是一种 LIN28 抑制剂,可有效抑制 LIN28:let-7 结合 (IC50: 7 μM)、消除 LIN28 介导的 let-7 前体寡尿苷化 (IC50: 27 μM),在 LIN28 驱动的癌症研究中具有潜在应用价值,并可通过抑制恶性疟原虫冷休克蛋白 (PfCoSP) 与 DNA 及 α/β 微管蛋白的相互作用而对恶性疟原虫产生抑制作用。
LIN28-IN-1(化合物 5)是一种 RNA 结合与调节蛋白 LIN28 的抑制剂,可与 LIN28 冷休克结构域 (CSD) 结合,有效抑制 LIN28 与 let-7 miRNA 的相互作用 (IC50: 5.4 μM),阻断 LIN28 对表观遗传基因调控的负面影响,并显著抑制表达 LIN28 的 JAR 癌细胞增殖 (IC50: 6.4 μM)。